Greyson ND,Noyek AM.Clinical Otolaryngology[A].Maisey Mn,Britton KE,Gilday DL.ClinicalNuclear Medicine[C].2 nd.L ondon:Chapman& Hall L td,1991.4 6 0 .
[2]
Goldrosen MH,Biddle WC,Pancook J,et al.Biodistribution,Pharmacokinetic,and Imaging StudiesWith186Re- labeled NR- L U- 10 Whole Antibody in L SI74 T Colonic Tumor- bearing Mice[J].CancerRes,1990 ,50 :7973.
[3]
[2 ] Goeckler EF.Skeletal L ocalization of Samarium - 153Chelates:Potential Therapeutic Bone Agents[J].JNucl Med,1987,2 8:4 95.
[4]
[2 ] Vanderheyden JL,Gofinch S,Srinivasan A,et al.Preparation and Characterization of Rhenium- 186 -labeled NR- Co- 0 2 F(ab) 2 :a New Anti- CEA Antibody Fragment for Radioimmunotherapy[J].JNuclMed,1989,30 :793.
Fritziberg AR,Beaumier P,Vanderheyden JL ,et al.Radioimmunotherapy Using Re- 186 :a NudeMouse Model Relevant to Man[J].JNucl Med,1989,30 :779.
[8]
Maxon HR ,Scohroder L E,Thomas SR,et al.Re- 186 (Sn) HEDP for Treatment of Painful OsseousMetastases:Initial Clinical Experience in 2 0 Patients With Hormoneresistant Prostate Cancer [J].Radiology,1990 ,176 :155.
[9]
[4 ] E John ML ,Thakur J,De Fulvio MR,et al.Rhenium- 186 - labeled Monoclonal Antibodies for Radioim-munotherapy:Preparation and Evaluation[J].JNucl Med,1993,34:2 6 0 .
[10]
[6 ] Hashimoto K.L abelling of Aminomethylenephosphonate Derivatives With Generator Produced188Re,and a Study of Their Stability[J].Appl Radit Isot,1999,51:30 7.
[11]
Hashimoto K.Synthesis of188Re- HEDP Complex Using Carrier- free188Re,and a Study of Its Stability[J].Appl Radit Isot,1998,4 9:351.
Deutsch E,Libson K,The Chemistry of Rhenium and Technetium as Related to the Use of Isotopes ofThese Elements in Therapeutic and Diagnostic Nuclear Medicine[J].Nucl Med Biol,1986 ,13:4 4 5.
